Robert B. Bazemore
Director/Board Member at ARDELYX, INC.
Net worth: 18 200 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Hung | M | 66 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 6 years |
| Grant Bogle | M | 66 | 5 years | |
| Justin Renz | M | 52 | 4 years | |
| Moses Makunje | M | 46 | 4 years | |
| Robert Felsch | M | - | 4 years | |
| David Mott | M | 58 | 15 years | |
| Kim Blickenstaff | M | 71 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 5 years |
| Kathryn Falberg | F | 63 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 4 years |
| Mike Raab Raab | M | 59 | 15 years | |
| Tony Vernon | M | 68 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 5 years |
| Elizabeth Grammer | F | 60 | 12 years | |
| Caitlin Lowie | F | - | 2 years | |
| Muna Bhanji | F | 61 | 3 years | |
| Laura Williams | M | 61 | 4 years | |
| Michelle Doig | F | 50 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 3 years |
| Onaiza Cadoret-Manier | F | 60 | 4 years | |
| William Bertrand | M | 59 | 9 years | |
| Jan Lundberg | M | 70 | 6 years | |
| Daniel Welch | M | 66 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 4 years |
| Richard Rodgers | M | 57 | 10 years | |
| Anne Mulcahy | F | 70 | 15 years | |
| Robert D. Mashal | M | - | - | |
| Charles B. Knapp | M | 77 |
University of Georgia
| 37 years |
| Susan Rodriguez | F | 60 | 4 years | |
| Stacy Markel | F | 59 | 5 years | |
| Robert Blanks | M | 64 | 11 years | |
| Peter Fasolo | M | 61 | 14 years | |
| David Hanley | M | 54 | 3 years | |
| Erin Graves | M | - | 7 years | |
| Gary Hattersley | M | 57 | 5 years | |
| Kerry Wentworth | F | 51 | 2 years | |
| Dong Fang Liu | M | 54 | 2 years | |
| Claudio Nessi | M | 56 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | - |
| Charon Spencer | F | - | 1 years | |
| David Rosenbaum | M | 63 | 14 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Gould | M | 69 | 8 years | |
| Mark E. Kaufmann | M | 56 | 9 years | |
| Andrew Singer | M | 53 | 2 years | |
| Matthew Stuckley | M | - | 14 years | |
| Hugh O'Dowd | M | 59 | 4 years | |
| Sanj Patel | M | 54 | 7 years | |
| W. Barkley | M | - |
University of Georgia
| 8 years |
| Matthew Ros | M | 57 | 5 years | |
| Suzanne Fleming | F | 63 | 2 years | |
| Cary Pfeffer | M | 61 | 5 years | |
| Robert Tepper | M | 68 | 7 years | |
| Eric S. Lander | M | 67 | 7 years | |
| Tai Ching Ho | M | 62 | 6 years | |
| Joseph Scodari | M | 71 | 9 years | |
| Felix Baker | M | 55 | 15 years | |
| Beth Seidenberg | M | 67 | 11 years | |
| Jolie Siegel | F | 47 | 2 years | |
| Joseph Beaulieu | M | 43 | 5 years | |
| Christine Poon | F | 71 | 9 years | |
| Kevin Conroy | M | 58 | 5 years | |
| Rosemary Crane | F | 64 | 6 years | |
| Geoffrey A. Block | M | 58 | 4 years | |
| Meryl Zausner | F | 67 | 3 years | |
| Patrick O'brien | M | 60 |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | 8 years |
| Bryan Pinciaro | M | - | 1 years | |
| John F. Weidenbruch | M | 63 | 5 years | |
| Annalisa Jenkins | M | 58 | 5 years | |
| Keith Santorelli | M | - | - | |
| Julie DiCarlo | F | - | - | |
| Sarah L. Colamarino | F | - | 13 years | |
| Kelly M. Smith | M | - |
University of Georgia
| 4 years |
| Jennifer Fox | F | 53 | 3 years | |
| Jeffrey W. Jacobs | M | 61 | 13 years | |
| Victoria Richon | M | 65 | 3 years | |
| Stephen Biggar | M | 53 | 4 years | |
| Richard Pops | M | 62 | 12 years | |
| Peter Wirth | M | 73 | 3 years | |
| Gordon Ringold | M | 73 | 7 years | |
| Stephen Davis | M | 63 | 4 years | |
| Thomas Malley | M | 55 | 9 years | |
| Michael Paul Krensavage | M | - |
University of Georgia
| 5 years |
| Richard Davenport | M | - |
University of Georgia
| 6 years |
| Thomas Tisch | M | 69 | 3 years | |
| Stephen Sherwin | M | 75 | 5 years | |
| Barry Quart | M | 67 | 3 years | |
| Steven Cotton | M | - |
University of Georgia
| 5 years |
| Mark Loeffler | M | - |
University of Georgia
| 7 years |
| Robert Kamen | M | 79 | 5 years | |
| Oleg Nodelman | M | 47 | 2 years | |
| Mike Debnar | M | - |
University of Georgia
| 4 years |
| Scott Weiselberg | M | 53 |
University of Georgia
| 4 years |
| Dean C. Christians | M | - |
University of Georgia
| 4 years |
| Joel Philip Goodman | M | 56 |
University of Georgia
| 4 years |
| Steve Edwards | M | 54 |
University of Georgia
| 4 years |
| H. Duncan Moseley | M | - |
University of Georgia
| 4 years |
| Dean A. Adelman | M | 58 |
University of Georgia
| 4 years |
| Louis Norwood Jameson | M | - |
University of Georgia
| 3 years |
| Jeanine Gibbs Garvie | F | - |
University of Georgia
| 4 years |
| John Ashmore Pandtle | M | 53 |
University of Georgia
| 4 years |
| Paul Currie | M | 59 |
University of Georgia
| 4 years |
| Robert F. Ray | M | - |
University of Georgia
| 4 years |
| Paul Jorgensen | M | 54 |
University of Georgia
| 4 years |
| Alana Scott | F | - |
University of Georgia
| 4 years |
| Becky Bell | F | - |
University of Georgia
| 4 years |
| Christopher R. Smith | M | - |
University of Georgia
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert B. Bazemore
- Personal Network